Dr. Trevor Martin is the CEO and co-founder of Mammoth Biosciences, which addresses challenges across healthcare, agriculture, environmental monitoring, biodefense, and more through discovery of novel CRISPR systems to power the next generation of CRISPR-based synthetic biology products. Ursheet Parikh is a partner at the venture capital firm Mayfield, where he co-leads the Human and Planetary Health investment practice, which includes an investment in Mammoth. In this conversation with Stanford adjunct lecturer Ravi Belani, Martin and Parikh share their advice for building a platform biotech company with staying power.
Related
Karabo Morule,
Capital Art
African Art Activism through Fintech [Entire Talk]
Fintech can help collectors in Africa and beyond realize the opportunity in the African art market.
Karabo Morule,
Capital Art
African Art Activism through Fintech [Entire Talk]
Fintech can help collectors in Africa and beyond realize the opportunity in the African art market.
Connie Chan,
Andreessen Horowitz
Career Advice from a VC Pro [Entire Talk]
Seek out diverse life and work experiences to give yourself an edge.
Connie Chan,
Andreessen Horowitz
Career Advice from a VC Pro [Entire Talk]
Seek out diverse life and work experiences to give yourself an edge.
Austin Russell,
Luminar
Behind the Scenes of a Mega-Unicorn [Entire Talk]
Unconventional approaches can lead a startup to uncommon success.
Austin Russell,
Luminar
Behind the Scenes of a Mega-Unicorn [Entire Talk]
Unconventional approaches can lead a startup to uncommon success.
